Bluejay Diagnostics, Inc. · NASDAQ:BJDX
Braeden Lichti reported a 5.01% stake in Bluejay Diagnostics, Inc. (Schedule 13G)
Event Feb 5, 2026 · Filed Feb 5, 2026
Braeden Lichti reported a 5.01% stake in Bluejay Diagnostics, Inc., 35,500 shares, as a passive investor on Feb 5, 2026. Filed Feb 5, 2026 (Schedule 13G).
- Stake
- 5.01%
- Shares
- 35,500
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Northstrive Fund II LP | 1.55% | 11,000 |
| Braeden Lichti | 5.01% | 35,500 |
Source
Related
- Bluejay Diagnostics, Inc.
- Northstrive Fund II LP
- Bluejay Diagnostics, Inc. shareholders
- Schedule 13D/A · Northstrive Fund II LP · Jun 2, 2026
- Form 4 · Dey Indranil · Aug 18, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Hrt Financial LP · Jul 13, 2026
- Schedule 13G · Mitchell P. Kopin · Jun 5, 2026